Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 14/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4778063 | 0.89 | CHRM1 (0.48) | EPHX2CNR1TRPV1CHRM1 | |
| SCHEMBL4781101 | 0.89 | EPHX2 (0.51) | KDM4EEPHX2CNR1TRPV1CHRM1 | |
| SCHEMBL4779491 | 0.87 | TRPV1 (0.51) | EPHX2TRPV1 | |
| SCHEMBL4779566 | 0.83 | TRPV1 (0.50) | EPHX2CNR1TRPV1 | |
| SCHEMBL4779435 | 0.83 | EPHX2 (0.51) | ALDH1A1EPHX2CNR1TRPV1CHRM1 | |
| SCHEMBL4778894 | 0.83 | EPHX2 (0.49) | EPHX2CNR1TRPV1CHRM1CYP3A4 | |
| SCHEMBL4780302 | 0.83 | TRPV1 (0.52) | KDM4EALDH1A1MAPTTRPV1CYP3A4 | |
| SCHEMBL4776335 | 0.82 | TRPV1 (0.53) | KDM4EALDH1A1MAPTEPHX2TRPV1 | |
| SCHEMBL4779427 | 0.82 | EPHX2 (0.51) | KDM4EALDH1A1MAPTEPHX2CNR1 | |
| SCHEMBL4774265 | 0.82 | TRPV1 (0.52) | EPHX2CNR1TRPV1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008010061-A2 | 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-01-24 | — | — | WO | disclosed |